-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-staging_research-protocol.pdf
May 20, 2013 - However, stage is the key determinant of the
management strategy. … that is compared against the stage established by the reference standard. … Stage reclassification or clinical decision impact. … Stage reclassification. … The change in stage of the cancer after imaging, compared with the stage
determined based on information
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/colorectal-cancer-staging_research-protocol.pdf
May 20, 2013 - However, stage is the key determinant of the
management strategy. … that is compared against the stage established by the reference standard. … Stage reclassification or clinical decision impact. … Stage reclassification. … The change in stage of the cancer after imaging, compared with the stage
determined based on information
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Type_of_Care/Prevention
February 19, 2021 - ever received pneumococcal vaccination
69.0
78.7
12.3%
Breast cancer diagnosed at advanced stage … (regional, distant stage, or local stage with tumor greater than 2 cm) per 100,000 women age 40 and … over
84.5
74.2
13.8%
Colorectal cancer diagnosed at advanced stage (tumors diagnosed at regional … or distant stage) per 100,000 population age 50 and over
63.8
48.9
30.4%
Cervical cancer … diagnosed at advanced stage (all invasive tumors) per 100,000 women age 20 and over
10.5
7.7
36.0%
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary4/lung-cancer-screening
July 30, 2013 - Because early-stage lung cancer is associated with lower mortality than late-stage disease, early detection … Stage II: 0.3% ( n = 4) vs. 0.2% (n = 2)
Stage IIIA: 0.6% ( n = 7) vs. 0.3% ( n = 4)
Stage … : 31/35
Stage IA: 20/16
Stage IB: 2/1
Stage IIA: 4/4
Stage IIB: 0 … /2
Stage IIIA: 2/4
Stage IIIB: 0/2
Stage IV: 1/0
Unknown: 0/2
… I: 58%
Stage II: 17%
Stage III: 30%
Stage IV: 7%
Additional procedures
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary4/lung-cancer-screening-december-2013
July 30, 2013 - Because early-stage lung cancer is associated with lower mortality than late-stage disease, early detection … NR
Stage IV: 17% vs. 15% vs. … : 31/35
Stage IA: 20/16
Stage IB: 2/1
Stage IIA: 4/4
Stage IIB: 0 … /2
Stage IIIA: 2/4
Stage IIIB: 0/2
Stage IV: 1/0
Unknown: 0/2
… I: 58%
Stage II: 17%
Stage III: 30%
Stage IV: 7%
Additional procedures
-
effectivehealthcare-admin.ahrq.gov/products/lung-cancer-staging/research
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
cds.ahrq.gov/sites/default/files/cds/artifact/106/AMIA_presentation.pptx
January 01, 2012 - onto building decision support and putting it into practice
5
5
How We Designed Healthy Weight
Stage … 1:
Freehand mockup
Stage 2
Wireframe mockup
Stage 3
Interactive module
Stage 4
User testing, feedback … Stage 5
Redesign, Enhance, Evaluate
6
Stage 1
Quick, easy, low overhead, adaptable
Stage 2
Layout … , spacing, internal workflow (white box testing)
Stage 3
Interactivity, data handling, processing speed
-
effectivehealthcare.ahrq.gov/products/renal-cancer/clinician
July 18, 2017 - for localized renal cell carcinoma range from greater than 85 percent to 95 percent, depending on the stage … Thermal ablation and active surveillance are considered options for patients with clinical stage T1a … Radical nephrectomy is recommended as the standard of care for most patients with clinical stage T2 tumors … CKD stage ≥3: RR 0.88 (0.60 to 1.30)
CKD stage ≥3b: RR 2.78 (0.47 to 16.54)
CKD stage ≥4: RR 0.76 … CKD stage ≥3: RR 0.39 (0.30 to 0.51)
CKD stage ≥3b: RR 0.37 (0.26 to 0.53)
CKD stage ≥4: RR 0.76
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_clinician.pdf
July 01, 2017 - localized renal
cell carcinoma range from greater than 85 percent to 95
percent, depending on the stage … Thermal ablation
and active surveillance are considered options for patients
with clinical stage T1a … Radical nephrectomy is recommended as the standard of care
for most patients with clinical stage T2 … CKD stage ≥3: RR 0.88 (0.60 to 1.30)
CKD stage ≥3b: RR 2.78 (0.47 to 16.54)
CKD stage ≥4: RR 0.76 ( … CKD stage ≥3: RR 0.39 (0.30 to 0.51)
CKD stage ≥3b: RR 0.37 (0.26 to 0.53)
CKD stage ≥4: RR 0.76 (0.54
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/renal-cancer_clinician.pdf
July 01, 2017 - localized renal
cell carcinoma range from greater than 85 percent to 95
percent, depending on the stage … Thermal ablation
and active surveillance are considered options for patients
with clinical stage T1a … Radical nephrectomy is recommended as the standard of care
for most patients with clinical stage T2 … CKD stage ≥3: RR 0.88 (0.60 to 1.30)
CKD stage ≥3b: RR 2.78 (0.47 to 16.54)
CKD stage ≥4: RR 0.76 ( … CKD stage ≥3: RR 0.39 (0.30 to 0.51)
CKD stage ≥3b: RR 0.37 (0.26 to 0.53)
CKD stage ≥4: RR 0.76 (0.54
-
hcup-us.ahrq.gov/db/vars/ds_stage1/kidnote.jsp
September 01, 2008 - TOOLS
KID Description of Data Elements
DS_Stage1 - Disease Staging: Stage … This severity measure includes the disease category and stage for the principal diagnosis and predictive … Uniform Values
Variable Description Value Value Description DS_Stage1 Disease Staging: Stage … of Principal Disease Category n.nn Principal Stage .
-
hcup-us.ahrq.gov/db/vars/ds_stage1/nisnote.jsp
September 01, 2008 - TOOLS
NIS Description of Data Elements
DS_Stage1 - Disease Staging: Stage … This severity measure includes the disease category and stage for the principal diagnosis and predictive … Uniform Values
Variable Description Value Value Description DS_Stage1 Disease Staging: Stage … of Principal Disease Category n.nn Principal Stage .
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/erythropoiesis-stimulating-agents-utilization_research.pdf
February 01, 2011 - to 8 percent among beneficiaries in Stage I; from 13 percent to
7 percent in Stage II; from 23 percent … Stage II: The inclusion criteria for the stage II population included beneficiaries:
(1) enrolled in … Stage IV: The inclusion criteria for the stage IV population included beneficia-
ries: (1) enrolled in … Stage V: The inclusion criteria for the stage V population included beneficiaries:
(1) enrolled in Part … Stage VI: The inclusion criteria for the stage VI population included beneficia-
ries: (1) enrolled in
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/erythropoiesis-stimulating-agents-utilization_research.pdf
February 01, 2011 - to 8 percent among beneficiaries in Stage I; from 13 percent to
7 percent in Stage II; from 23 percent … Stage II: The inclusion criteria for the stage II population included beneficiaries:
(1) enrolled in … Stage IV: The inclusion criteria for the stage IV population included beneficia-
ries: (1) enrolled in … Stage V: The inclusion criteria for the stage V population included beneficiaries:
(1) enrolled in Part … Stage VI: The inclusion criteria for the stage VI population included beneficia-
ries: (1) enrolled in
-
www.uspreventiveservicestaskforce.org/uspstf/document/addendum-to-screening-for-ovarian-cancer-evidence-update-for-the-us-preventive-services-task-force-reaffirmation-recommendation-statement/ovarian-cancer-screening-2012
April 15, 2012 - of ovarian tumors are diagnosed at this stage. … Additionally, the majority (72 percent) of screen-detected cancer cases were late-stage (Stage III or … Overall, 48.3 percent of the invasive cancer cases were early stage (Stage I or II), with no significant … stage distribution difference between the two groups. … might be more likely to identify early-stage, slow-growing tumors than later screening cycles.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/QtuWfedsMmUb_sAuKWdsGg
December 31, 2014 - , only 15 percent of ovarian tumors are
diagnosed at this stage. … Additionally, the majority (72
percent) of screen-detected cancer cases were late-stage (Stage III … Overall,
48.3 percent of the invasive cancer cases were early stage (Stage I or II), with no significant … stage distribution difference between the two groups. … might be more likely to identify
early-stage, slow-growing tumors than later screening cycles.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0491-140827.pdf
February 19, 2014 - that there is insufficient clarity regarding the most
effective imaging modalities to diagnose and stage … A review of the
evidence on imaging modalities to diagnose and stage lung cancer could aid in the
development
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0491-140827.pdf
February 19, 2014 - that there is insufficient clarity regarding the most
effective imaging modalities to diagnose and stage … A review of the
evidence on imaging modalities to diagnose and stage lung cancer could aid in the
development
-
www.qualitymeasures.ahrq.gov/sites/default/files/wysiwyg/ncepcr/resources/job-aid-model-pdsa.pdf
May 17, 2021 - Four stages of a PDSA cycle
Stage 1. … Stage 2. … Stage 3. Study – The practice analyzes the data collected during the Do stage.
Stage 4.
-
www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/ncepcr/resources/job-aid-model-pdsa.pdf
May 17, 2021 - Four stages of a PDSA cycle
Stage 1. … Stage 2. … Stage 3. Study – The practice analyzes the data collected during the Do stage.
Stage 4.